[1]
Gupta, P., Baishnab, S. and Rewri, P. 2021. Comparative evaluation of efficacy and safety of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.1% ophthalmic solution in patients with vernal keratoconjunctivitis. International Journal of Basic & Clinical Pharmacology. 10, 5 (Apr. 2021), 552–560. DOI:https://doi.org/10.18203/2319-2003.ijbcp20211652.